Is CME Group (CME) Undervalued On Strong Earnings And Fresh Rate Expectations?
Why CME Group’s latest earnings matter for investors
CME Group (CME) has just posted third quarter and nine month results that show higher revenue, net income, and earnings per share versus a year earlier, along with fresh rate expectations signaled through its FedWatch tool.
CME Group’s share price has picked up speed recently, with a 30-day share price return of 15.2% and a 90-day gain of 13.9%, even though the 7-day move was slightly down at 0.8%. That short-term pullback sits against a much stronger backdrop. The 1-year total shareholder return is 18.6% and the 3-year total shareholder return is 65.1%, indicating that momentum has been building as investors react to higher recent earnings and fresh rate expectations reflected in the FedWatch tool.
Scan other exchanges and trading platforms that are showing similar momentum to CME Group by checking our curated list of 19 high quality undiscovered gems as this earnings season reshapes where capital is flowing.
CME Group has rallied hard into these results, yet still trades at a discount to analyst targets while sitting at a premium to some fair value estimates. Is the market’s caution on the recent move rational or overstated?
Most Popular Narrative: 4% Undervalued
Against a last close of $303.14, the most followed narrative pegs CME Group’s fair value at $316, which suggests only a modest gap that hinges on how durable its volumes, data fees, and product pipeline prove to be.
The main thing that has to go right is that CME Group continues to extend its product set and technology, including tokenized cash, a potential stablecoin, and new contracts across asset classes, while defending its position against competitors in rates, energy, and perpetual futures.
The numbers and current valuation indicate that CME Group is fairly valued, with investors already accounting for strong margins, structural market data revenue, and potential benefits from new clearing and collateral efficiency initiatives.
See why 56 investors see CME Group as 4% undervalued.
Result: Fair Value of $316 (UNDERVALUED)
Still, analyst concerns about rising competition in key contracts and a rich P/E multiple leave room for sentiment to swing if CME Group underdelivers.
Find out about the key risks to this CME Group narrative.
Another view on CME Group’s valuation
The first narrative framed CME Group as modestly undervalued around a fair value of $316. The SWS DCF model tells a different story. On that framework, the stock at $303.14 sits above an estimated future cash flow value of $254.96, which screens as overvalued rather than cheap.
That gap suggests investors are paying a premium to the modeled cash flows, which might be fine if you put more weight on CME Group’s earnings resilience than on discounted cash flow math. Or it could mean less of a cushion if sentiment cools. Which camp do you fall into when the numbers disagree like this?
Look into how the SWS DCF model arrives at its fair value.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out CME Group for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 33 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
Next Steps
If this mix of optimism and caution around CME Group leaves you undecided, treat it as a prompt to inspect the numbers yourself and move early on your own conclusions. To frame that view against both the upside narrative and the concerns already flagged by the market, start with 3 key rewards and 2 important warning signs.
Ready to hunt for your next idea beyond CME Group?
Do not stop at one opportunity. Broaden your watchlist with fresh ideas filtered by quality, value, and risk so you are not reacting after the crowd moves.
- Zero in on potential mispricings by scanning a 33 high quality undervalued stocks that filters for quality businesses trading below their assessed worth.
- Prioritize resilience and balance sheet strength by working through a list of solid balance sheet and fundamentals (24 results) that screens for financially robust companies.
- Dial back volatility in your portfolio by using a 29 resilient stocks with low risk scores focused on stocks with lower overall risk scores.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com